Mycoplasma Contamination: The Silent Threat in Your Lab
If your cells look healthy but your experiments keep failing, this might be why
When reproducibility suddenly breaks down, growth rates drop without explanation, or viability readings come back low despite cells looking perfectly fine — most researchers instinctively reach for the usual suspects: the medium, the serum, the protocol. But the real cause is often somewhere else entirely.
Mycoplasma. Because it does not kill cells, contamination is easy to miss — and by the time it is finally detected, months of accumulated data may already be compromised. Across the published literature, estimates suggest that approximately 15–35% of cell lines in culture laboratories worldwide carry Mycoplasma contamination. It is one of the most common yet most underappreciated sources of error in cell biology research.
Why Is It So Hard to Detect?
Mycoplasma are bacteria without a cell wall. That single characteristic is what makes them so difficult to catch and eliminate.
They are small enough to pass through a 0.2 μm sterilization filter. Filter sterilization does not remove Mycoplasma from media.
They are invisible under a standard light microscope. Phase contrast microscopy cannot detect them either, so there is no way to spot contamination by eye.
Common antibiotics do not work. Beta-lactams such as penicillin and ampicillin target cell wall synthesis — a mechanism that is irrelevant to organisms that have no cell wall.
Cells do not die. Contaminated cultures continue to grow and look normal. This is precisely why contamination goes unnoticed for so long, quietly corrupting data the whole time.
The species most commonly responsible for contamination in cell culture are M. orale (originating from the human oral cavity), M. hyorhinis (from porcine serum), and M. arginini (transmitted via serum or human contact). Of these, M. orale is most often traced back to the researcher working at the bench.
Where Does It Come From? — Main Routes of Contamination
Mycoplasma contamination does not appear overnight. It enters gradually over time and only becomes detectable once it reaches a sufficient threshold. Understanding the routes is the first step toward preventing it.
| Source |
Typical Scenario |
Risk Level |
| Laboratory personnel |
Oral Mycoplasma transmitted during culture work without a mask |
⚠️⚠️⚠️ Very high |
| Cell line sharing |
Received cell lines already contaminated at source institution |
⚠️⚠️⚠️ Very high |
| Serum (FBS) |
Fetal bovine serum containing M. hyorhinis or other species |
⚠️⚠️ High |
| Trypsin |
Porcine pancreas-derived trypsin acting as a contamination vector |
⚠️⚠️ High |
| Shared equipment |
CO2 incubators, pipettes, media bottles shared between users |
⚠️ Medium |
| Cross-contamination |
Contaminated and clean cells co-housed in the same incubator |
⚠️ Medium |
Two scenarios account for the majority of cases. The first is working at the biosafety cabinet without a mask. Oral droplets released during talking, coughing, or sneezing can carry Mycoplasma directly into open culture vessels. The second is putting a new cell line into use without testing it first. Even from a reputable source, contamination can arise during shipping and handling. Test before use — every time.
Why Does It Matter? — The Silent Corruption of Experimental Data
Mycoplasma does not kill cells. But it interferes with nearly every experimental parameter you care about.
Growth kinetics shift. Mycoplasma competes for nutrients, which can slow cell proliferation — but in some cases it induces cytokine secretion that drives abnormally rapid growth. Either way, your growth curves and doubling time data become unreliable.
Viability measurements become untrustworthy. Mycoplasma disrupts cellular metabolism and membrane function, distorting viability assay results. The percentage readout on your cell counter may not accurately reflect the true health of the culture.
Downstream experiments are affected across the board. Transfection efficiency drops. Mycoplasma-derived RNA contaminates RNA-seq and PCR results. Drug screening assays yield inconsistent IC50 values and aberrant dose-response curves.
In GMP-based cell therapy manufacturing, a confirmed Mycoplasma positive can mean batch rejection or full process shutdown — with direct consequences for product timelines and regulatory filings.
Taken together, Mycoplasma contamination is one of the most reliable ways to compromise experimental reproducibility, which is why routine monitoring is not optional.
⚠️ The core problem
Mycoplasma is dangerous not because it kills cells, but because it keeps cells alive while quietly corrupting data — often for months before anyone notices. The later the detection, the greater the damage.
How to Check — Detection Methods Compared
Senescent cells aren’t simply ‘old and tired.’ Depending on context, they can be both beneficial and harmful.
| Method |
Sensitivity |
Turnaround |
Cost |
Notes |
| PCR-based |
★★★★★ |
Hours |
Medium |
Lab standard. Most widely used |
| Fluorescent staining (Hoechst) |
★★☆☆☆ |
1–2 days |
Low |
Screening only; not for confirmation |
| Culture method |
★★★★☆ |
2–4 weeks |
High |
Required for GMP / regulatory compliance |
| ELISA / kit-based |
★★★☆☆ |
Hours |
Medium |
Easy to use without specialized equipment |
| Next-gen sequencing (NGS) |
★★★★★ |
Days |
Very high |
Species-level identification; research use |
PCR — Why It’s the Standard
PCR is fast, sensitive, and easy to implement with a commercial kit. By targeting the Mycoplasma 16S rRNA gene with universal primers, a single run covers the major contaminating species. One thing to watch for is DNA quality: inhibitors in culture supernatant can affect results, so using a kit with an internal positive control is strongly recommended.
Fluorescent Staining (Hoechst 33258) — For Screening Only
With Hoechst 33258 or DAPI staining, small punctate fluorescent signals may be visible in the cytoplasm surrounding the nucleus — an indicator that Mycoplasma may be present. However, sensitivity is low and low-level contamination is easily missed. This method is not suitable for definitive diagnosis; use it only as a preliminary screen alongside PCR.
Culture Method — May Be Required in GMP Settings
This classical approach involves culturing for up to four weeks and offers high sensitivity and specificity, but requires time and specialized expertise. Regulatory agencies may require this method for cell therapy and other GMP products.
When to Test — Timing Matters
In contamination detection, timing is everything. Without a routine testing schedule, you will almost certainly find out too late.
Test in these situations — without exception
- Upon receiving any new cell line — regardless of source, test before use.
- Routine scheduled testing — at least monthly is generally recommended; more frequently for high-priority or heavily used lines.
- When something seems off — unexplained growth slowdown, viability drop, or morphological changes: test immediately.
- Before sharing cells with another lab — contaminated cells passed to colleagues spread the problem.
- Long-passaged cell lines — established lines in long-term use still need periodic testing.
Prevention Is Far Better Than Treatment
Dealing with an active contamination is far more costly than preventing one. Four core principles cover most of the risk.
Wear a mask — non-negotiable
Oral Mycoplasma is the single most common route of contamination. Always wear a mask during cell culture work and minimize unnecessary talking in front of the biosafety cabinet. It sounds simple, and it is — but it is also the most effective single preventive measure.
Quarantine new cell lines until tested
Any cell line received from outside the lab should be kept in a dedicated quarantine incubator until confirmed Mycoplasma-negative. A supplier’s ‘Mycoplasma-free’ certification is not a substitute for your own testing — contamination can occur during transit, and conditions may have changed since the supplier’s last test.
Use certified reagents
Use FBS lots that carry Mycoplasma-negative certification. For trypsin, consider recombinant or certified alternatives given the contamination risk associated with porcine pancreas-derived products. Never share media bottles between cell lines.
Maintain a frozen stock — your insurance policy
Banking early-passage cells that have been confirmed Mycoplasma-negative is both a prevention strategy and a contingency plan. If contamination does occur, replacing from a clean frozen stock is faster and more reliable than antibiotic treatment. Log passage number and test history so you can trace back to a specific time point if needed.
Penicillin/Streptomycin Won’t Help — Elimination Antibiotics
This is one of the most common misconceptions in cell culture. Penicillin has no activity against Mycoplasma, as it targets cell wall synthesis and Mycoplasma have no cell wall. Streptomycin likewise has only limited effectiveness for Mycoplasma prevention or elimination. A different class of antibiotic is required.
| Antibiotic |
Mechanism of Action |
Considerations |
| Ciprofloxacin |
DNA gyrase inhibition (cell wall-independent) |
Potential cytotoxicity; avoid prolonged use |
| Doxycycline |
30S ribosomal inhibition; blocks protein synthesis |
Resistance may develop with repeated use |
| Azithromycin |
50S ribosomal inhibition |
Some Mycoplasma species show resistance |
| Commercial kits (e.g., BM-Cyclin) |
Alternating dual-antibiotic regimen |
Follow kit protocol strictly |
⚠️ The limits of antibiotic treatment
Antibiotic treatment does not guarantee complete eradication. PCR confirmation of a negative result is required after treatment. For important cell lines, replacing from a clean frozen stock is a more reliable solution.
If You Get a Positive Result — Step-by-Step Response
Knowing the response sequence in advance makes a positive result much less disruptive.
- Isolate immediately. Separate contaminated cells from all other cultures and stop using the shared incubator.
- Assess the scope. Test all other cell lines that shared the same incubator or media bottles.
- Replace or treat. If a clean frozen stock exists, replacement is the preferred option. If not, attempt antibiotic treatment — and confirm negative by PCR afterward.
- Decontaminate the incubator. Clean all interior surfaces thoroughly with 70% ethanol or a dedicated decontamination agent.
- Identify the source. Determine how contamination entered and update your SOPs accordingly.
- Re-test after recovery. Confirm Mycoplasma-negative by PCR at least two weeks after completing antibiotic treatment.
Closing Thoughts
Mycoplasma is dangerous precisely because it does not kill cells. The typical pattern is months of silent data corruption before anyone realizes something is wrong.
Prevention beats remediation, and routine testing beats both. Building monthly PCR testing into your lab schedule, committing to masks and cell line quarantine, and keeping clean frozen stocks on hand — these three habits are the most practical defense against Mycoplasma contamination.
While automated cell counters cannot detect Mycoplasma directly, they are valuable for monitoring the changes in cell count and viability that contamination can cause.
Logos Biosystems — Cell Counting Solutions for Mycoplasma Monitoring
- LUNA-FX7™ – Fluorescence + brightfield automated cell counter. Quickly confirm cell count and viability when contamination is suspected
- LUNA-III™ – Simple, accurate brightfield automated cell counter
- CELENA® X – High-Content Imaging System for monitoring morphological changes and analyzing 3D structures
Frequently Asked Questions (FAQ)
Q1. Do I have to discard all data generated from a contaminated culture?
A. Not necessarily. If you can estimate when contamination began and have a confirmed negative test result predating that point, earlier data may still be usable. Data generated after the estimated onset of contamination should be interpreted cautiously — reproducibility cannot be assumed.
Q2. I use Penicillin/Streptomycin — am I covered?
A. No. Penicillin targets cell wall synthesis, and Mycoplasma have no cell wall. Streptomycin has very limited efficacy against Mycoplasma as well. Routine antibiotics in your culture medium do not protect against Mycoplasma. Prevention requires aseptic technique and regular testing.
A. No. Mycoplasma range from 0.1 to 0.8 μm in size, and some species pass through a 0.2 μm filter. Filter sterilization should not be assumed to remove Mycoplasma from media.
Q4. The supplier says the cell line is Mycoplasma-free. Do I still need to test?
A. Yes. Contamination can occur during shipping and handling after the supplier’s test was performed, and conditions may change over time. Every incoming cell line should be tested upon arrival, regardless of documentation.
References
- Drexler HG, Uphoff CC. Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention. Cytotechnology. 2002;39(2):75–90.
- Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998;62(4):1094–1156.
- Nikfarjam L, Farzaneh P. Prevention and detection of mycoplasma contamination in cell culture. Cell J. 2012;13(4):203–212.
- Young L et al. A new era for Mycoplasma detection in cell culture. Nat Methods. 2010;7:439–440.
- Uphoff CC, Drexler HG. Eradication of mycoplasma contaminations from cell cultures. Curr Protoc Mol Biol. 2014;106:28.4.1–12.
Looking for an automated solution for cell analysis and viability measurement?
Explore the LUNA automated cell counter and our full range of cell analysis solutions at
www.logosbio.com.
Looking for the Korean version? Click here.
